Menu Search
Equities

Resmed Inc

RMD:ASX

Resmed Inc

Actions
  • Price (AUD)32.78
  • Today's Change-0.32 / -0.97%
  • Shares traded1.04m
  • 1 Year change-4.35%
  • Beta--
Data delayed at least 20 minutes, as of May 17 2024 07:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		RMD:NYQ since
announced		Transaction
value
KC Machine LLCDeal completed29 Sep 202329 Sep 2023Deal completed45.66%2.60m
Somnoware Healthcare Systems IncDeal completed05 Jul 202305 Jul 2023Deal completed1.83%--
Data delayed at least 15 minutes, as of May 18 2024 00:00 BST.

Institutional shareholders

2.96%Per cent of shares held by top holders
HolderShares% Held
Vanguard Investments Australia Ltd.as of 30 Apr 20248.72m0.59%
First Sentier Investors (Hong Kong) Ltd.as of 31 Jan 20247.28m0.50%
Schroder Investment Management (Singapore) Ltd.as of 31 Jan 20245.61m0.38%
Australian Foundation Investment Co. Ltd. (Invt Mgmt)as of 30 Jun 20234.39m0.30%
First Sentier Investors (Australia) IM Ltd.as of 31 Jan 20244.26m0.29%
FIL Investment Management (Singapore) Ltd.as of 31 Mar 20243.38m0.23%
BetaShares Capital Ltd.as of 30 Apr 20243.23m0.22%
Russell Investment Management Ltd.as of 28 Mar 20242.32m0.16%
FIL Investment Management (Australia) Ltd.as of 31 Mar 20242.27m0.15%
Veritas Asset Management LLPas of 30 Sep 20232.15m0.15%
More ▼
Data from 30 Jun 2023 - 16 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.